XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.20.2

Capital Stock | 6 Months Ended
--- | ---
Sep. 30, 2020
Equity and Share-based Compensation [Abstract] |
Capital Stock | Capital Stock (a) Common Shares The Company had 500 million authorized Class A voting shares and 500 million authorized Class B non-voting shares at September 30, 2020 and March 31, 2020. The table below outlines common shares reserved for future issuance:
| September 30, 2020 |  | March 31, 2020
| (Amounts in millions)
Stock options and SARs outstanding | 25.6 |  |  | 35.7 |
Restricted stock and restricted share units — unvested | 9.6 |  |  | 3.7 |
Common shares available for future issuance | 16.4 |  |  | 11.5 |
Shares reserved for future issuance | 51.6 |  |  | 50.9 |
(b) Share-based Compensation On September 15, 2020, the Company’s shareholders approved an amendment to the Lions Gate Entertainment Corp. 2019 Performance Incentive Plan (the “2019 Plan”) previously adopted by the Board of Directors of the Company to increase the maximum number of the Company’s common shares that may be issued or transferred pursuant to awards under the 2019 Plan by an additional 10.0 million shares so that the new aggregate share limit under the 2019 Plan is 16.1 million common shares (not including shares that were originally approved for issuance under the Company’s prior stock incentive plans that have become available for issuance under the 2019 Plan pursuant to the terms of the 2019 Plan). The Company recognized the following share-based compensation expense during the three and six months ended September 30, 2020 and 2019:
| Three Months Ended |  | Six Months Ended
| September 30, |  | September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
| (Amounts in millions)
Compensation Expense: |  |  |  |  |  |  |
Stock options | $ | 5.0 |  |  | $ | 5.2 |  |  | $ | 9.3 |  |  | $ | 8.8 |
Restricted share units and other share-based compensation | 14.4 |  |  | 8.5 |  |  | 23.3 |  |  | 13.3 |
Share appreciation rights | 3.4 |  |  | 0.8 |  |  | 4.6 |  |  | 1.7 |
| 22.8 |  |  | 14.5 |  |  | 37.2 |  |  | 23.8 |
Impact of accelerated vesting on equity awards(1) | 2.8 |  |  | — |  |  | 2.8 |  |  | 0.3 |
Total share-based compensation expense | $ | 25.6 |  |  | $ | 14.5 |  |  | $ | 40.0 |  |  | $ | 24.1 |
Tax impact(2) | (5.3) |  |  | (3.1) |  |  | (8.2) |  |  | (5.1) |
Reduction in net income | $ | 20.3 |  |  | $ | 11.4 |  |  | $ | 31.8 |  |  | $ | 19.0 |
___________________ (1)Represents the impact of the acceleration of certain vesting schedules for equity awards pursuant to certain severance arrangements. (2)Represents the income tax benefit recognized in the unaudited condensed consolidated statements of operations for share-based compensation arrangements prior to the effects of changes in the valuation allowance. Share-based compensation expense, by expense category, consisted of the following:
| Three Months Ended |  | Six Months Ended
| September 30, |  | September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
| (Amounts in millions)
Share-Based Compensation Expense: |  |  |  |  |  |  |
Direct operating | $ | 0.5 |  |  | $ | 0.3 |  |  | $ | 0.9 |  |  | $ | 0.4 |
Distribution and marketing | 0.2 |  |  | 0.1 |  |  | 0.3 |  |  | 0.2 |
General and administration | 22.1 |  |  | 14.1 |  |  | 36.0 |  |  | 23.2 |
Restructuring and other | 2.8 |  |  | — |  |  | 2.8 |  |  | 0.3 |
| $ | 25.6 |  |  | $ | 14.5 |  |  | $ | 40.0 |  |  | $ | 24.1 |
The following table sets forth the stock option, SARs, restricted stock and restricted share unit activity during the six months ended September 30, 2020:
| Stock Options and SARs |  | Restricted Stock and Restricted Share Units
| Class A Voting Shares |  | Class B Non-Voting Shares |  | Class A Voting Shares |  | Class B Non-Voting Shares
| Number of Shares |  | Weighted-Average Exercise Price |  | Number of Shares |  | Weighted-Average Exercise Price |  | Number of Shares |  | Weighted-Average Grant-Date Fair Value |  | Number of Shares |  | Weighted-Average Grant-Date Fair Value
| (Number of shares in millions)
Outstanding at March 31, 2020 | 7.2 |  |  | $26.21 |  | 28.5 |  |  | $19.03 |  | — |  | (1) | $14.89 |  | 3.8 |  |  | $14.63
Granted | — |  |  | — |  |  | 3.3 |  | (2) | $8.71 |  | — |  | (1) | $9.87 |  | 7.8 |  |  | $7.77
Options exercised or restricted stock or RSUs vested | — |  |  | — |  |  | — |  |  | — |  |  | — |  | (1) | $16.57 |  | (1.9) |  |  | $14.04
Awards canceled in exchange program | (1.1) |  |  | $31.56 |  | (4.1) |  |  | $26.49 |  | — |  |  | — |  |  | — |  |  | — |
Awards issued in exchange program | 0.1 |  |  | $7.70 |  | 0.8 |  |  | $7.13 |  | — |  |  | — |  |  | — |  |  | — |
Forfeited or expired | (0.7) |  |  | $31.54 |  | (8.4) |  |  | $16.48 |  | — |  |  | — |  |  | (0.1) |  |  | $10.83
Outstanding at September 30, 2020 | 5.5 |  |  | $24.19 |  | 20.1 |  |  | $16.41 |  | — |  | (1) | $11.10 |  | 9.6 |  |  | $9.17
__________________ (1)Represents less than 0.1 million shares. (2)During the six months ended September 30, 2020, the Company granted 2.1 million SARs. Exchange Program On January 10, 2020, the Company’s Board of Directors authorized, and on April 2, 2020, the Company’s shareholders approved, a stock option and share appreciation rights exchange program (the “Exchange Program”) that permitted certain current employees to exchange certain outstanding stock options and share appreciation rights with exercise prices substantially above the current market price of the Company’s Class A voting shares and the Company’s Class B non-voting shares for a lesser number of stock options and share appreciation rights that have a fair value that is lower than the fair value of the “out of the money” stock options and share appreciation rights. The program began on April 9, 2020 and was completed on May 7, 2020. As a result of this program 1.1 million outstanding eligible stock options and share appreciation rights of Class A voting shares were exchanged for 0.1 million new stock options and share appreciation rights at an exercise price of $7.70 per share and 4.3 million outstanding eligible stock options and share appreciation rights of Class B non-voting shares were exchanged for 0.8 million new stock options and share appreciation rights at an exercise price of $7.13. (c) Share Repurchases During the three months ended September 30, 2020, the Company did not repurchase any common shares. During the six months ended September 30, 2020, the Company repurchased 0.2 million of its Class A voting shares for an aggregate cost of $1.0 million, with an average repurchase price per share of $5.75. During the three and six months ended September 30, 2019 the Company did not repurchase any common shares. To date, approximately $288.1 million common shares have been repurchased, leaving approximately $179.9 million of authorized potential purchases.

X
- Definition Equity and Share-based Compensation [Abstract] + References No definition available. + Details
Name: | lgfa_EquityAndShareBasedCompensationAbstract
Namespace Prefix: | lgfa_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration